Lactoferrin, Fecal, Quantitative
Also known as: Fecal Lactoferrin, Fecal Leukocytes, IBD-Scan®, Stool Lactoferrin
Use
An in vitro diagnostic aid to distinguish patients with active inflammatory bowel disease (IBD) from those with inactive IBD, as well as from noninflammatory irritable bowel syndrome (IBS).
Special Instructions
Specimen collection should avoid contamination with urine and sanitary materials. The stool should be collected in a clean, screw-capped plastic vial without preservatives, and refrigerated during transport.
Limitations
The test may not be appropriate for immunocompromised individuals, patients with a history of HIV, hepatitis B and C, infectious diarrhea within the past six months, or those who have had a colostomy or ileostomy within the last month. Fecal lactoferrin levels should be interpreted in conjunction with a full patient evaluation since other intestinal ailments, including gastrointestinal infections and colorectal cancer, may also raise lactoferrin levels.
Methodology
Immunoassay (ELISA)
Biomarkers
LOINC Codes
- 42924-1
- 42924-1
Result Turnaround Time
4-8 days
Related Documents
For more information, please review the documents below
Specimen
Stool
Volume
1 g
Minimum Volume
0.5 g
Container
Clean, screw-capped, plastic vial with no preservatives
Collection Instructions
Do not contaminate outside of container; do not overfill container. Loose/watery stools are acceptable. Ensure that no toilet tissue/sanitary materials are present in the submitted specimen. Ship refrigerated at 2°C to 8°C.
Storage Instructions
Refrigerate.
Causes for Rejection
Nonfecal sample received (eg, serum, plasma, urine); stool contaminated with urine; preserved stool received (eg, 10% formalin, sodium acetate formalin, or polyvinyl alcohol)
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | >14 days |